Fresenius | FRE - Fremdkapital

Aktienkurs
44.05
Täglich Wechseln
-0.71 -1.58%
Monatlich
-8.81%
Jährlich
20.47%
Q2 Prognose
42.30




Fremdkapital Veränderung Datum
Akzo Nobel EUR 3.67B 13M 2025-12
Alcon AG USD 4.59B 0 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
BASF EUR 18.48B 447M 2025-12
Bayer EUR 31.83B 877M 2025-12
Beiersdorf EUR 117M 15M 2025-12
DaVita Healthcare Partners USD 10.16B 19.88M 2025-12
Demant DKK 18.98B 3.71B 2025-12
E.ON EUR 34.05B 869M 2025-12
Essilor EUR 9.46B 92M 2025-12
Fresenius EUR 10.8B 1.49B 2025-09
Fresenius Medical Care EUR 4.85B 4.49B 2025-12
Getinge SEK 8.92B 640M 2025-12
Givaudan CHF 4.19B 448M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
GN Store Nord DKK 8.9B 9M 2025-12
GRIFOLS EUR 8.47B 624.81M 2025-12
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.73B 277M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Philips EUR 6.93B 303M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
RWE EUR 15.51B 129M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Smith & Nephew USD 3.3B 22M 2025-12